Kiker Wealth Management LLC purchased a new stake in shares of DaVita Inc. (NYSE:DVA - Free Report) during the 4th quarter, according to the company in its most recent disclosure with the SEC. The fund purchased 5,468 shares of the company's stock, valued at approximately $818,000.
Other large investors have also recently added to or reduced their stakes in the company. Royal London Asset Management Ltd. raised its holdings in DaVita by 6.0% in the 4th quarter. Royal London Asset Management Ltd. now owns 21,926 shares of the company's stock valued at $3,279,000 after buying an additional 1,242 shares during the period. OVERSEA CHINESE BANKING Corp Ltd purchased a new stake in shares of DaVita in the 4th quarter valued at approximately $983,000. Boston Partners lifted its holdings in shares of DaVita by 48.9% in the 4th quarter. Boston Partners now owns 89,453 shares of the company's stock worth $13,387,000 after acquiring an additional 29,394 shares during the last quarter. Intech Investment Management LLC boosted its position in shares of DaVita by 1.2% during the 4th quarter. Intech Investment Management LLC now owns 27,265 shares of the company's stock worth $4,077,000 after purchasing an additional 328 shares during the period. Finally, Advisors Asset Management Inc. increased its holdings in DaVita by 24.6% in the 4th quarter. Advisors Asset Management Inc. now owns 22,686 shares of the company's stock valued at $3,393,000 after purchasing an additional 4,485 shares during the last quarter. 90.12% of the stock is currently owned by institutional investors and hedge funds.
DaVita Stock Up 0.1 %
DVA stock traded up $0.19 during mid-day trading on Tuesday, reaching $150.60. The company had a trading volume of 662,227 shares, compared to its average volume of 783,786. DaVita Inc. has a fifty-two week low of $125.64 and a fifty-two week high of $179.60. The company has a market capitalization of $12.05 billion, a price-to-earnings ratio of 14.02, a price-to-earnings-growth ratio of 1.07 and a beta of 0.99. The company has a debt-to-equity ratio of 23.18, a quick ratio of 1.21 and a current ratio of 1.26. The firm has a fifty day simple moving average of $158.40 and a 200 day simple moving average of $157.57.
DaVita (NYSE:DVA - Get Free Report) last issued its quarterly earnings results on Thursday, February 13th. The company reported $2.24 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $2.14 by $0.10. DaVita had a net margin of 7.31% and a return on equity of 115.48%. Analysts forecast that DaVita Inc. will post 10.76 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
A number of research analysts have commented on DVA shares. StockNews.com cut DaVita from a "buy" rating to a "hold" rating in a research note on Friday. Sanford C. Bernstein set a $184.00 target price on DaVita in a report on Friday, February 21st. Barclays lifted their target price on DaVita from $164.00 to $169.00 and gave the company an "equal weight" rating in a research report on Tuesday, February 18th. Finally, Cowen reissued a "hold" rating on shares of DaVita in a research report on Tuesday, February 18th. One analyst has rated the stock with a sell rating, five have given a hold rating and one has given a buy rating to the company. Based on data from MarketBeat.com, DaVita has an average rating of "Hold" and a consensus price target of $166.33.
View Our Latest Stock Analysis on DaVita
DaVita Profile
(
Free Report)
DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.
See Also
Before you consider DaVita, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DaVita wasn't on the list.
While DaVita currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
